
|Articles|November 1, 2004
Intensive post-Tx cancer surveillance often unneeded
San Francisco-Urologists need to become more frugal in monitoring patients after urologic cancer treatment, advises Steven C. Campbell, MD, PhD, associate professor and co-director of urologic oncology at Loyola University Medical Center, Maywood, IL.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
4
Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS
5






